156 related articles for article (PubMed ID: 36362610)
1. Psychological Distress in Patients Treated for Renal Cell Carcinoma: A Systematic Literature Review.
Vartolomei L; Schmidinger M; Vartolomei MD; Shariat SF
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362610
[TBL] [Abstract][Full Text] [Related]
2. Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinoma.
Ajaj R; Cáceres JOH; Berlin A; Wallis CJD; Chandrasekar T; Klaassen Z; Ahmad AE; Leao R; Finelli A; Fleshner N; Goldberg H
World J Urol; 2020 Oct; 38(10):2547-2554. PubMed ID: 31893313
[TBL] [Abstract][Full Text] [Related]
3. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
DiNatale RG; Xie W; Becerra MF; Silagy AW; Attalla K; Sanchez A; Mano R; Marcon J; Blum KA; Benfante NE; Voss MH; Motzer RJ; Coleman J; Choueiri TK; Reznik E; Russo P; Heng DYC; Hakimi AA
Eur Urol Oncol; 2020 Feb; 3(1):47-56. PubMed ID: 31735646
[TBL] [Abstract][Full Text] [Related]
5. The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy.
Packiam VT; Tyson Ii MD; Tsivian M; Lohse CM; Boorjian SA; Cheville JC; Costello BA; Leibovich BC; Thompson RH
Urol Oncol; 2020 Feb; 38(2):41.e19-41.e27. PubMed ID: 31761613
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Graham J; Wells JC; Donskov F; Lee JL; Fraccon A; Pasini F; Porta C; Bowman IA; Bjarnason GA; Ernst DS; Rha SY; Beuselinck B; Hansen A; North SA; Kollmannsberger CK; Wood LA; Vaishampayan UN; Pal SK; Choueiri TK; Heng DYC
Eur Urol Oncol; 2019 Nov; 2(6):643-648. PubMed ID: 31411994
[TBL] [Abstract][Full Text] [Related]
8. Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic.
Chan VW; Tan WS; Leow JJ; Tan WP; Ong WLK; Chiu PK; Gurung P; Pirola GM; Orecchia L; Liew MPC; Lee HY; Wang Y; Chen IA; Castellani D; Wroclawski ML; Mayor N; Sathianathen NJ; Braga I; Liu Z; Moon D; Tikkinen K; Kamat A; Meng M; Ficarra V; Giannarini G; Teoh JY
World J Urol; 2021 Dec; 39(12):4295-4303. PubMed ID: 34031748
[TBL] [Abstract][Full Text] [Related]
9. The effect of perioperative blood transfusion on survival after renal cell carcinoma nephrectomy: A systematic review and meta-analysis.
Liu Y; Deng X; Wen Z; Huang J; Wang C; Chen C; Yang X
Front Oncol; 2023; 13():1092734. PubMed ID: 36874080
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life and Psychological Distress among Patients with Small Renal Masses.
Vartolomei L; Cotruș A; Stanciu C; Delcea C; Tozzi M; Lievore E; Crocetto F; Del Giudice F; Lucarelli G; Muto M; Ferro M
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887708
[TBL] [Abstract][Full Text] [Related]
11. Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab.
Flammia RS; Hoeh B; Hohenhorst L; Sorce G; Chierigo F; Panunzio A; Tian Z; Saad F; Leonardo C; Briganti A; Antonelli A; Terrone C; Shariat SF; Graefen M; Chun FKH; Montorsi F; Gallucci M; Karakiewicz PI
Semin Oncol; 2022 Apr; 49(2):136-140. PubMed ID: 35610060
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic burdens of recurrence following nephrectomy for intermediate high- or high-risk renal cell carcinoma: A retrospective analysis of Surveillance, Epidemiology, and End Results-Medicare data.
Sundaram M; Song Y; Rogerio JW; Zhang S; Bhattacharya R; Adejoro O; Carley C; Zhu JJ; Signorovitch J; Haas NB
J Manag Care Spec Pharm; 2022 Oct; 28(10):1149-1160. PubMed ID: 36048895
[No Abstract] [Full Text] [Related]
13. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma in young patients is associated with poorer prognosis.
Lee LS; Yuen JS; Sim HG
Ann Acad Med Singap; 2011 Sep; 40(9):401-6. PubMed ID: 22065033
[TBL] [Abstract][Full Text] [Related]
15. Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease-A National Register Study.
Almdalal T; Sundqvist P; Harmenberg U; Hellström M; Lindskog M; Lindblad P; Lundstam S; Ljungberg B
Eur Urol Open Sci; 2022 May; 39():22-28. PubMed ID: 35528783
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
[TBL] [Abstract][Full Text] [Related]
18. Factors related to lymph node sampling at the time of surgery in children, adolescents, and young adults with unilateral non-metastatic renal cell carcinoma.
Saltzman AF; Stokes W; Walker J; Cost NG
J Pediatr Urol; 2019 May; 15(3):259.e1-259.e7. PubMed ID: 30819622
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
